NAXIVA

Trial description
Phase II Neoadjuvant study of AXItinib for reducing extent of venous tumour thrombus in clear cell renal cell cancer with Venous invAsion
Contact name
Dr Grant Stewart
Trial start date
Monday, December 4, 2017
Trial end date
Monday, September 30, 2019
Trial tumour type
Kidney
Show on Radiotherapy
No